LMT
50
3
MDT
60
-3
CAG
37
3
APH
56
-2
CHD
35
3
DTE
38
-4
NTAP
67
2
UNM
53
3
SHW
53
-2
ADI
78
-2
MMM
61
-2
LEN
40
2
XOM
48
-12
AMGN
31
-5
XRX
37
-2
CRM
59
-5
DOV
71
2
NRG
52
-8
TRIP
60
2
FOX
59
2
LMT
50
3
MDT
60
-3
CAG
37
3
APH
56
-2
CHD
35
3
DTE
38
-4
NTAP
67
2
UNM
53
3
SHW
53
-2
ADI
78
-2
MMM
61
-2
LEN
40
2
XOM
48
-12
AMGN
31
-5
XRX
37
-2
CRM
59
-5
DOV
71
2
NRG
52
-8
TRIP
60
2
FOX
59
2
Financhill
Back

Praxis Precision Medicines, Inc. 10K Form

Buy
62

PRAX
Praxis Precision Medicines, Inc.

Last Price:
$247.85
Seasonality Move:
11.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRAX News And Ratings

See the #1 stock for the next 7 days that we like better than PRAX

PRAX Financial Statistics

Sales & Book Value

Annual Sales: $8.6M
Cash Flow: $-64.7M
Price / Cash Flow: 0
Annual Sales: $16.23
Price / Book: 18.05

Profitability

EPS (TTM): -12.90420
Net Income (TTM): $-273M
Gross Margin: $8.2M
Return on Equity: -67.75%
Return on Assets: -61.29%

Praxis Precision Medicines, Inc. Earnings Forecast

Key Praxis Precision Medicines, Inc. Financial Ratios

  • The Gross Profit Margin over the past 7 years for PRAX is 95.81%.
  • The Selling, General & Administrative Expenses for PRAX have been equal to 658.31% of Gross Profit Margin.
  • The Research & Development expenses have been 1,781.98% of Revenue.
  • The Net Earning history of PRAX is -2,137.48% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Praxis Precision Medicines, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PRAX
CUSIP: 74006W
Website: praxismedicines.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.18
Quick Ratio: 5.05

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRAX Technical Analysis vs Fundamental Analysis

Buy
62
Praxis Precision Medicines, Inc. (PRAX) is a Buy

Is Praxis Precision Medicines, Inc. a Buy or a Sell?